Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nrk (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRK mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NRK mRNA | CTD | PMID:32109520 and PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of NRK mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | NRK (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of NRK gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | increases expression | ISO | Nrk (Mus musculus) | 6480464 | bisphenol S results in increased expression of NRK mRNA | CTD | PMID:30951980 | all-trans-retinoic acid | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Tretinoin results in increased expression of NRK mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of NRK mRNA | CTD | PMID:30951980 | antirheumatic drug | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of NRK mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | NRK (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of NRK mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases mutagenesis | ISO | NRK (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of NRK gene | CTD | PMID:25435355 | benzo[a]pyrene | affects methylation | ISO | NRK (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of NRK 5' UTR and Benzo(a)pyrene affects the methylation of NRK promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NRK mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NRK gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NRK mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | NRK (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of NRK mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | ISO | Nrk (Mus musculus) | 6480464 | bisphenol A results in increased expression of NRK mRNA | CTD | PMID:30951980 and PMID:34585602 | bisphenol A | affects methylation | ISO | Nrk (Mus musculus) | 6480464 | bisphenol A affects the methylation of NRK promoter | CTD | PMID:27334623 | bisphenol A | decreases methylation | ISO | Nrk (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of NRK promoter | CTD | PMID:27312807 | bisphenol F | increases expression | ISO | Nrk (Mus musculus) | 6480464 | bisphenol F results in increased expression of NRK mRNA | CTD | PMID:30951980 | chlordecone | increases expression | ISO | Nrk (Mus musculus) | 6480464 | Chlordecone results in increased expression of NRK mRNA | CTD | PMID:33711761 | dextran sulfate | decreases expression | ISO | Nrk (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of NRK mRNA | CTD | PMID:35093514 | dibutyl phthalate | decreases expression | ISO | Nrk (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of NRK mRNA | CTD | PMID:21266533 | dioxygen | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of NRK mRNA | CTD | PMID:24236059 | dorsomorphin | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of NRK mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | NRK (Homo sapiens) | 6480464 | entinostat results in increased expression of NRK mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA | CTD | PMID:27188386 | fulvestrant | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NRK gene | CTD | PMID:31601247 | geldanamycin | increases expression | ISO | NRK (Homo sapiens) | 6480464 | geldanamycin results in increased expression of NRK mRNA | CTD | PMID:26705709 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NRK mRNA | CTD | PMID:33387578 | isoflurane | increases methylation | ISO | Nrk (Mus musculus) | 6480464 | Isoflurane results in increased methylation of NRK mRNA | CTD | PMID:35249202 | lead diacetate | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased methylation of NRK intron | CTD | PMID:33445541 | lead(0) | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased methylation of NRK intron | CTD | PMID:33445541 | mercury dibromide | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA | CTD | PMID:27188386 | nickel atom | decreases expression | ISO | NRK (Homo sapiens) | 6480464 | Nickel results in decreased expression of NRK mRNA | CTD | PMID:25583101 | panobinostat | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA | CTD | PMID:27188386 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NRK mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | Nrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenylmercury acetate | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of NRK mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA | CTD | PMID:27188386 | potassium chromate | increases expression | ISO | NRK (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of NRK mRNA | CTD | PMID:22714537 | potassium dichromate | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of NRK protein | CTD | PMID:23718831 | pyrogallol | decreases expression | ISO | Nrk (Mus musculus) | 6480464 | Pyrogallol results in decreased expression of NRK mRNA | CTD | PMID:20362636 | SB 431542 | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sevoflurane | increases methylation | ISO | Nrk (Mus musculus) | 6480464 | Sevoflurane results in increased methylation of NRK mRNA | CTD | PMID:35249202 | sunitinib | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Sunitinib results in increased expression of NRK mRNA | CTD | PMID:31533062 | trichostatin A | increases expression | ISO | NRK (Homo sapiens) | 6480464 | trichostatin A results in increased expression of NRK mRNA | CTD | PMID:24935251 | valproic acid | increases methylation | ISO | NRK (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NRK gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | Nrk (Mus musculus) | 6480464 | Valproic Acid results in increased expression of NRK mRNA | CTD | PMID:24896083 | valproic acid | increases expression | ISO | NRK (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NRK mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | NRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
